Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Seres Therapeutics, Inc. | mcrb-ex322_84.htm |
| EX-32.1 - EX-32.1 - Seres Therapeutics, Inc. | mcrb-ex321_10.htm |
| EX-31.2 - EX-31.2 - Seres Therapeutics, Inc. | mcrb-ex312_83.htm |
| EX-31.1 - EX-31.1 - Seres Therapeutics, Inc. | mcrb-ex311_7.htm |
| EX-23.1 - EX-23.1 - Seres Therapeutics, Inc. | mcrb-ex231_8.htm |
| EX-10.14 - EX-10.14 - Seres Therapeutics, Inc. | mcrb-ex1014_133.htm |
| EX-4.3 - EX-4.3 - Seres Therapeutics, Inc. | mcrb-ex43_134.htm |
| 10-K - 10-K - Seres Therapeutics, Inc. | mcrb-10k_20191231.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SERES THERAPEUTICS, INC.
|
|
|
|
|
|
|
Legal Name of Subsidiary |
|
|
|
Jurisdiction of Organization |
|
Seres Therapeutics Securities Corporation |
|
|
|
Massachusetts |
|
Seres Therapeutics UK Limited Seres Therapeutics Netherlands B.V. |
|
|
|
United Kingdom The Netherlands |